4hlw: Difference between revisions
Jump to navigation
Jump to search
m Protected "4hlw" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 3: | Line 3: | ||
The entry 4hlw is ON HOLD | The entry 4hlw is ON HOLD | ||
Authors: M | Authors: Ravi, S.N.M., Leblanc, E., Axerio-Cilies, P., Labriere, C., Frewin, K., Hassona, M.D.H., Lack, N.A., Han, F.Q., Guns, E.S., Young, R., Ban, F., Rennie, P.S., Cherkasov, A. | ||
Description: Targeting the Binding Function 3 (BF3) Site of the Human Androgen Receptor Through Virtual Screening. 2. Development of 2-((2-phenoxyethyl) thio)-1H-benzoimidazole derivatives. | Description: Targeting the Binding Function 3 (BF3) Site of the Human Androgen Receptor Through Virtual Screening. 2. Development of 2-((2-phenoxyethyl) thio)-1H-benzoimidazole derivatives. | ||
Revision as of 16:23, 8 November 2012
Unreleased structure
The entry 4hlw is ON HOLD
Authors: Ravi, S.N.M., Leblanc, E., Axerio-Cilies, P., Labriere, C., Frewin, K., Hassona, M.D.H., Lack, N.A., Han, F.Q., Guns, E.S., Young, R., Ban, F., Rennie, P.S., Cherkasov, A.
Description: Targeting the Binding Function 3 (BF3) Site of the Human Androgen Receptor Through Virtual Screening. 2. Development of 2-((2-phenoxyethyl) thio)-1H-benzoimidazole derivatives.